Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Average Rating of 'Moderate Buy' from Brokerages

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six analysts currently following the stock, according to reports. While one analyst has rated the stock as a hold, five others have assigned a buy recommendation to the company. The average one-year target price among the analysts who have rated the stock in the past year is set at $27.67.

Recently, several equities research analysts have shared their views on Kestra Medical Technologies. Wells Fargo & Company began coverage on the shares with an "overweight" rating while setting a $28.00 target price. Wolfe Research also initiated coverage, giving the stock an "outperform" rating and a $29.00 price objective. Piper Sandler started coverage as well, assigning an "overweight" rating with a target of $27.00. Stifel Nicolaus similarly began coverage, issuing a "buy" rating and a price objective of $28.00. Meanwhile, The Goldman Sachs Group initiated coverage but assigned a "neutral" rating with a $24.00 target price.

Kestra Medical Technologies Price Performance

During mid-day trading on Monday, shares of NASDAQ KMTS saw a slight increase of $0.02, reaching a price of $23.45. Approximately 44,548 shares traded hands, a volume lower than the average of 290,871. The stock has seen a twelve-month low of $20.00 and a high of $25.98.

Kestra Medical Technologies Company Profile

Kestra Medical Technologies is a commercial-stage company that specializes in wearable medical devices and digital healthcare solutions. The company is dedicated to improving patient outcomes, particularly in cardiovascular disease, through technologies designed for monitoring and therapeutic interventions that are user-friendly and connected. The centerpiece of their offerings is the Cardiac Recovery System platform, which combines monitoring, treatment, digital health, and patient support services into a seamless solution.

Investment Consideration

Investors may be curious about whether to invest $1,000 in Kestra Medical Technologies now. While the stock carries a Moderate Buy rating with a promising outlook, it is essential to note that analysts have highlighted five other stocks they recommend more confidently. Investors should consider these recommendations as they evaluate their options in the market.

stock, analysts, invest